Write rigorous, accurate cardiology science for general audiences—not doctors...
Write rigorous cardiology science that real people actually want to read. Same accuracy as an academic editorial. Zero intimidation.
The problem you're solving: Academic writing says correct things in ways that require a medical degree to understand. Dumbed-down content oversimplifies to the point of being wrong.
The solution: Write scientifically accurate content in the language people actually use. An 8th grader should understand it. A cardiologist should find no errors.
What "for people" means:
Never start with: "The STEP-HFpEF trial randomized 529 patients..."
Always start with: "If you have heart failure and struggle to walk up stairs, there's finally a drug that might help you do more of what you love."
The trial is evidence. The story is why anyone should care.
Never write: "The hazard ratio was 0.65 (95% CI 0.51-0.82), representing a 35% relative risk reduction."
Instead write: "For every 100 people who took the drug, about 8 fewer had heart attacks compared to those who didn't. That's a meaningful difference—roughly 1 in 12 people benefited."
Always convert to:
Academic style: "The DAPA-HF trial (McMurray et al., NEJM 2019) demonstrated that dapagliflozin reduced the composite of worsening heart failure or cardiovascular death by 26% (HR 0.74, 95% CI 0.65-0.85)."
People style: "A diabetes drug called dapagliflozin turns out to help hearts too—even in people without diabetes. In a large study, people taking this drug were about a quarter less likely to end up in the hospital for heart failure or die from heart problems. Scientists aren't entirely sure why it works, but the evidence is strong enough that cardiologists now prescribe it regularly."
The citation goes in your references section. The reader gets the understanding.
Use PubMed MCP exactly as you would for academic writing:
PubMed:search_articles for finding trials and evidencePubMed:get_article_metadata for detailsPubMed:get_full_text_article when availableTarget: 5-8 solid references from major journals (NEJM, JAMA, Lancet, JACC, Circulation, EHJ).
Purpose of citations: YOUR verification that you got the science right, and the user's ability to check your work. NOT to impress readers.
Before writing, answer:
What's the one thing readers need to understand?
Why should someone care?
What's the story arc?
What's the "so what" for a reader's life?
Unlike the rigid 7-section editorial, structure should serve the story:
Option A: Problem → Discovery → Meaning
Option B: Surprising Fact → Explanation → Implications
Option C: Person's Story → Science → Takeaway
Write like a knowledgeable friend who happens to be a cardiologist—not like an expert talking down.
DO:
DON'T:
General rule: If YOU need the trial name to verify the science, keep it in your references. The reader almost never needs it.
When to mention trial names: Only when the name itself is widely known by patients (rare) or when you're writing a longer piece where you'll reference the same trial multiple times.
How to handle:
Convert ALL statistics to human terms:
| Academic | For People |
|---|---|
| 35% relative risk reduction | About 1 in 3 fewer events |
| HR 0.74 (95% CI 0.65-0.85) | Roughly a quarter less likely |
| NNT = 25 | For every 25 people treated, 1 person benefits |
| p < 0.001 | Very strong evidence (drop this entirely usually) |
| Median follow-up 4.2 years | After about 4 years |
| Primary composite endpoint | The main things researchers were counting |
When to use numbers:
See references/plain-language-guide.md for complete list. Quick reference:
| Medical | Plain |
|---|---|
| myocardial infarction | heart attack |
| cardiovascular death | death from heart problems |
| hospitalization for heart failure | ending up in the hospital because your heart is struggling |
| composite endpoint | combination of outcomes |
| randomized controlled trial | well-designed study where patients were randomly assigned |
| placebo | sugar pill / inactive treatment |
| statistically significant | unlikely to be a coincidence |
| hazard ratio | risk comparison |
| mechanism of action | how the drug works |
| pharmacokinetics | how the drug moves through your body |
| adverse events | side effects |
| contraindicated | shouldn't be used |
| comorbidities | other health conditions |
| titration | adjusting the dose |
| prognosis | likely outcome |
Before finalizing, confirm:
At the end, include a "Sources" or "The Evidence" section:
Format:
## The Evidence
1. The heart failure drug study mentioned: McMurray JJV et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381(21):1995-2008. DOI: 10.1056/NEJMoa1911303
2. The weight loss medication study: Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. DOI: 10.1056/NEJMoa2307563
This section serves two purposes:
Short form (tweets, posts): 280-500 words
Medium form (newsletter, article): 800-1500 words
Long form (deep dive): 2000-3000 words
Write as: An interventional cardiologist who genuinely enjoys explaining medicine to interested laypeople. Not talking down. Not dumbing down. Just... talking.
First person is okay:
Reader relationship:
START: User wants to explain cardiology science to general audience
│
├─→ What's the source material?
│ ├─ Trial/Paper → Research via PubMed MCP
│ ├─ Topic/Question → Research via PubMed MCP
│ └─ User-provided PDF/abstract → Extract key points, verify via PubMed
│
├─→ Research phase
│ ├─ Use PubMed:search_articles for relevant trials
│ ├─ Get 5-8 references from major journals
│ ├─ Extract: What actually happened? What does it mean?
│ └─ Identify the human story
│
├─→ Writing phase
│ ├─ Lead with story/meaning, not data
│ ├─ Translate all statistics to human terms
│ ├─ Background trial names (references section)
│ ├─ Foreground understanding and implications
│ ├─ Keep language at 8th grade reading level
│ └─ Maintain full scientific accuracy
│
├─→ Verification phase
│ ├─ Would a cardiologist approve the accuracy?
│ ├─ Would an 8th grader understand it?
│ ├─ Is every claim backed by a citable reference?
│ └─ Have statistics been translated without distortion?
│
└─→ OUTPUT: Rigorous science in human language + reference section
Before delivering:
Academic (original editorial style): "The SELECT trial (Lincoff et al., NEJM 2023) randomized 17,604 adults with established cardiovascular disease and BMI ≥27 without diabetes to semaglutide 2.4 mg weekly or placebo. The primary endpoint—a composite of cardiovascular death, nonfatal MI, or nonfatal stroke—occurred in 6.5% of the semaglutide group versus 8.0% of the placebo group (HR 0.80, 95% CI 0.72-0.90, p<0.001), representing a 20% relative risk reduction over a median follow-up of 39.8 months."
For People (this skill): "Here's something that surprised even cardiologists: a weight loss drug might actually protect your heart—independent of how much weight you lose.
Researchers studied over 17,000 people who already had heart disease and were overweight or obese. Half got weekly injections of semaglutide (the active ingredient in Ozempic and Wegovy), and half got a placebo. After about three years, those on semaglutide were roughly 20% less likely to have a heart attack, stroke, or die from heart problems.
What's striking is this: the benefit showed up before people lost much weight. Something about the drug itself seems to protect blood vessels. Scientists are still working out exactly how, but the evidence was strong enough that cardiologists are now taking notice—especially for patients who have both heart disease and weight to lose.
The bottom line? If you have heart disease and are considering weight loss medications, this one might do double duty. Worth a conversation with your cardiologist."
Same facts. Different packaging. One requires medical training to appreciate. One doesn't.
references/plain-language-guide.md - Complete vocabulary translationsreferences/storytelling-patterns.md - Narrative structures that work